OurCrowd

JANUARY 13, 2021

David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap. Read more here.

digital therapeutics 28

digital therapeutics leadership board health 28

HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. in funding.

health 113

health digital therapeutics board support 113

HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. in funding.

health 91

health digital therapeutics board support 91

AsiaTechDaily

APRIL 30, 2022

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?

digital therapeutics 52

digital therapeutics health accelerator board 52

Angel Capital Association

MAY 18, 2020

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?

digital therapeutics 40

digital therapeutics hospitality angel capital economic development 40

OurCrowd

SEPTEMBER 15, 2020

a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ) Scientific Advisory Board will help develop and execute the Company’s strategic roadmap for refining, improving and expanding its digital therapeutics platform. Read more here.

board 36

board digital therapeutics development 36

Y Combinator

MARCH 2, 2021

The FDA is the federal regulatory body in the United States that oversees the development of medical products (e.g. Developing and bringing a product to market will, with the exception of a limited class of products 1 , require explicit FDA marketing approval. We describe the major ones here: Therapeutic Submissions.

startup 59

startup health development digital therapeutics 59